Siu LL - Search Results

1

Diaz-Padilla I, Siu LL. Diaz-Padilla I, et al. Among authors: siu ll. Expert Opin Investig Drugs. 2011 Apr;20(4):577-86. doi: 10.1517/13543784.2011.565329. Epub 2011 Mar 11. Expert Opin Investig Drugs. 2011. PMID: 21391890 Review.

2

A phase II study of temozolomide in advanced untreated pancreatic cancer.

Moore MJ, Feld R, Hedley D, Oza A, Siu LL. Moore MJ, et al. Among authors: siu ll. Invest New Drugs. 1998;16(1):77-9. doi: 10.1023/a:1006043332368. Invest New Drugs. 1998. PMID: 9740547 Clinical Trial.

3

Phase I and pharmacologic study of the human DNA methyltransferase antisense oligodeoxynucleotide MG98 given as a 21-day continuous infusion every 4 weeks.

Davis AJ, Gelmon KA, Siu LL, Moore MJ, Britten CD, Mistry N, Klamut H, D'Aloisio S, MacLean M, Wainman N, Ayers D, Firby P, Besterman JM, Reid GK, Eisenhauer EA. Davis AJ, et al. Among authors: siu ll. Invest New Drugs. 2003 Feb;21(1):85-97. doi: 10.1023/a:1022976528441. Invest New Drugs. 2003. PMID: 12795533 Clinical Trial.

4

Multidisciplinary Symposium on Head and Neck Cancer. 2 December 2005, Philadelphia, PA, USA.

Agulnik M, Siu LL. Agulnik M, et al. Among authors: siu ll. Expert Opin Pharmacother. 2006 Mar;7(4):489-94. doi: 10.1517/14656566.7.4.489. Expert Opin Pharmacother. 2006. PMID: 16503821

5

Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck.

Tang PA, Siu LL, Chen EX, Hotte SJ, Chia S, Schwarz JK, Pond GR, Johnson C, Colevas AD, Synold TW, Vasist LS, Winquist E. Tang PA, et al. Among authors: siu ll. Invest New Drugs. 2008 Jun;26(3):257-64. doi: 10.1007/s10637-007-9098-8. Epub 2007 Nov 24. Invest New Drugs. 2008. PMID: 18038218 Clinical Trial.

6

Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck.

Le Tourneau C, Siu LL. Le Tourneau C, et al. Among authors: siu ll. Curr Opin Oncol. 2008 May;20(3):256-63. doi: 10.1097/CCO.0b013e3282f9b575. Curr Opin Oncol. 2008. PMID: 18391623 Review.

7

Promising antitumor activity with MGCD0103, a novel isotype-selective histone deacetylase inhibitor.

Le Tourneau C, Siu LL. Le Tourneau C, et al. Among authors: siu ll. Expert Opin Investig Drugs. 2008 Aug;17(8):1247-54. doi: 10.1517/13543784.17.8.1247. Expert Opin Investig Drugs. 2008. PMID: 18616420 Review.

8

Cyclin-dependent kinase inhibitors as potential targeted anticancer agents.

Diaz-Padilla I, Siu LL, Duran I. Diaz-Padilla I, et al. Among authors: siu ll. Invest New Drugs. 2009 Dec;27(6):586-94. doi: 10.1007/s10637-009-9236-6. Epub 2009 Mar 5. Invest New Drugs. 2009. PMID: 19262992 Review.

9

A dose-escalation phase I trial of nimotuzumab, an antibody against the epidermal growth factor receptor, in patients with advanced solid malignancies.

You B, Brade A, Magalhaes JM, Siu LL, Oza A, Lovell S, Wang L, Hedley DW, Nicacio LV, Chen EX. You B, et al. Among authors: siu ll. Invest New Drugs. 2011 Oct;29(5):996-1003. doi: 10.1007/s10637-010-9444-0. Epub 2010 May 8. Invest New Drugs. 2011. PMID: 20454832 Clinical Trial.

10

A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours.

Diaz-Padilla I, Siu LL, San Pedro-Salcedo M, Razak AR, Colevas AD, Shepherd FA, Leighl NB, Neal JW, Thibault A, Liu L, Lisano J, Gao B, Lawson EB, Wakelee HA. Diaz-Padilla I, et al. Among authors: siu ll. Br J Cancer. 2012 Aug 7;107(4):604-11. doi: 10.1038/bjc.2012.319. Epub 2012 Jul 17. Br J Cancer. 2012. PMID: 22805331 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

447 results

Search Page

Filters